Award Ceremony and Scientific Webinar to the 2021 Promega Oncology Research Grant
June is Cancer Immunotherapy Month. On Tuesday June 1st, we will organize an online Award Ceremony and a scientific webinar. During this event the 1st, 2nd and 3rd place of the Promega Benelux Oncology Grant will be announced.
Find all event details and free registration on this page below:
Award Ceremony
The Oncology Research Grant is a funding opportunities for young academic researchers working in the field of Oncology and those who are taking their first steps in this interesting research field. In total Promega Benelux is awarding three grants valued at € 5.000, € 15.000 and € 25.000 in free Promega products.
Join the festive online award ceremony of our first Benelux Oncology Research Grant.
During this ceremony the jury will announce the winners. Next to the Award Ceremony, the talented finalists will present their plans and we have a scientific webinar by Dr. Mei Cong about "Developing Bioassays for Biologics to address Cancer Immunotherapy".
Date: June 1st.
Time: 15:00-17:00 (CEST Amsterdam, Brussels, Luxembourg)
Online event
Meet our finalists:
|
Name |
Affiliation |
Project Title |
|
Clothilde Claus |
Biochimie métabolique et moléculaire, Université de Mons, Mons |
Study of C1qBP-DUX4 interactions to develop new therapeutic tools for cancer |
|
Caitrín Crudden |
Cancer Center Amsterdam (CCA), VUmc |
Genome-wide siRNA screen to identify modulators of oncogenic exosome release |
|
Jorrit De Waele |
Center for Oncological Research (CORE), University of Antwerp |
Development of a CAR NK cell product optimized for potent cytotoxic functioning in the metabolically-challenging tumor microenvironment. |
|
Christophe Deben |
Center for Oncological Research (CORE), University of Antwerp |
Rationally designed drug combination screen in more physiologically relevant in vitro organoid models: can we improve personalized therapy for pancreatic cancer? |
|
Louise Gérard |
Laboratoire of Molecular Cancer Biology, URPhyM, Université de Namur, Namur |
Characterization of half ABCB transporters through the study of their localization, heterodimerization, and implication in cancer resistance |
|
Natalia Ortiz Zacarias |
LACDR, Leiden University |
Hijacking the proteasome: PROTACs as a novel therapeutic approach for targeting membrane proteins in cancer |
|
Nicolas Papadopoulos |
SIGN unit, Institut De Duve, UCLouvain, Brussels |
Structural Basis of Thrombopoietin Receptor Activation in Myeloproliferative Neoplasms |
|
Emily Ploeg |
Translational Surgical Oncology, UMCG, Groningen |
Blockade of the CD73 immune checkpoint on tumor-derived exosomes; a novel approach to enhance efficacy of cancer immunotherapy? |
|
Abhishek Sinha |
Cell & Chemical Biology, LUMC, Leiden |
Neddylation dynamics of E3 ubiquitin ligases during hypoxia and its impact on TGFβ signaling |
Grants / Prizes
1st Prize :
25.000 Euro
in free Promega products, to help you work on your oncology research project
2nd Prize is a Promega product bundle of up to € 15.000,-
3rd Prize is a Promega product bundle of up to € 5000
Scientific Webinar
Developing Bioassays for
Biologics to address Cancer Immunotherapy
Abstract: In the past ten years, biologics have emerged as promising new approaches to immunotherapy, which aims to utilize the patient’s own immune system to combat diseases such as cancer and autoimmunity. Some of these approaches include recombinant cytokines, immune checkpoint mAbs, bi-specific molecules, antibody-drug conjugates and chimeric antigen receptor (CAR) T cell therapies. The inherent complexity, functional heterogeneity, and sensitivity of biologics to external storage conditions present unique challenges in drug discovery and development, and the development and manufacture of these products must be tightly controlled to ensure consistent purity, potency, efficacy, and safety. This presentation is to demonstrate how Promega bioassays are designed to address drug mechanism of action (MOA) and are used throughout the biologics drug discovery and development workflow.
Speaker: Mei Cong, PhD, Research Director, Elite Access, Promega R&D
Join our festive Award Ceremony and Scientifc Webinar.
This is an online event, to join simply register below. You will receive login details a day before the event will take place